Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 2OTHER 1NIH 1FED 1

Study Type

Interventional 1

Sponsor

Conditions

Inflammatory Bowel Diseases 1Granulomatous Disease, Chronic 1Crohn Disease 1

Interventions

cabozantinib 1Specimen Handling 1Platinum Compounds 1Nivolumab 1Methoxsalen 1Ipilimumab 1Infliximab 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Crohn Disease × Infliximab × Clear all
NCT00325078 2015-12-29

Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease

National Institutes of Health Clinical Center (CC)

Phase 1/2 Terminated
40 enrolled 11 charts

Crohn Disease, Granulomatous Disease, Chronic, Inflammatory Bowel Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡